ArticleScientific reports2025
Web based AI-driven framework combining multi-modal data with CNN and LLM for Parkinson's disease diagnosis.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- From intelligent models to clinical tools: the evolving landscape of AI in medical imaging.Scientific reports · 2026Article
- Trends and challenges in imaging research of Parkinson's disease: a 10-year bibliometric analysis.Psychoradiology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Parkinson's disease (PD) is a progressive neurodegenerative disorder characterized by a wide spectrum of motor and non-motor symptoms, often leading to delayed or inaccurate diagnosis. Conventional diagnostic methods frequently suffer from limited sensitivity, scalability, and interpretability, thereby restricting their utility in clinical settings. To address these limitations, this study presents a novel AI-driven diagnostic framework that integrates multimodal data fusion, deep learning-based classification, and generative language modeling to improve diagnostic accuracy and enable personalized reporting. The proposed framework leverages the Parkinson's Progression Marker Initiative (PPMI) dataset, incorporating structural Magnetic resonance imaging (MRI), Single-Photon Emission Computed Tomography (SPECT) imaging, cerebrospinal fluid (CSF) biomarkers, and clinical assessments. Statistical analysis was employed to select 14 key biomarkers-including dopamine transporter SBR values and CSF protein levels-from a total of 21 features identified as clinically relevant. A 1D Convolutional Neural Network (1D-CNN) was developed and trained using 121 engineered features, comprising radiomic descriptors and biologically derived metrics. Preprocessing and extensive feature engineering were conducted prior to a 70:30 train-test split, with data augmentation applied to the training set to enhance model generalization. The classifier achieved an accuracy of 93.7%, surpassing baseline approaches and emphasizing the value of domain-informed feature design. To improve interpretability and clinician usability, a Mini ChatGPT-4.0 Large Language Model (LLM) was fine-tuned using approximately 1,000 domain-specific prompt-response pairs generated from literature, classifier-derived eXplainable AI (XAI) feature scores, and expert annotations. The generated responses were evaluated using a custom scoring metric (0.0-5.0) based on their semantic alignment with ground truth completions. This LLM module produces patient-specific diagnostic summaries and treatment suggestions. Additionally, a cloud-based interface was developed to facilitate real-time MRI uploads, automated inference, and chatbot-driven consultations. Overall, the framework demonstrates high diagnostic performance, transparency, and user accessibility, offering significant potential for real-world clinical deployment in PD diagnosis and decision support.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.